A pharmaceutical composition and a method for the treatment of gastric disorders and Helicobacter pylori in the stomach or duodenum comprising a zinc compound and a cyclodextrin or cyclodextrin derivative for instance selected from alpha -cyclodextrin, beta -cyclodextrin or gamma -cyclodextrin. The pharmaceutical composition may also include a pharmaceutically acceptable acidic compound such as a carboxylic acid.

Cosmetic mixtures made with zinc calcium aluminum borosilicate are provided. The zinc calcium aluminum borosilicate is made as glass and crushed into particles having small diameter sizes. The particles make up a powder that is then mixed with cosmetic ingredients to produce modified cosmetic products.

An underlayer made of a III-V semiconductor compound is formed on a given substrate, and a CrSb compound is epitaxially grown on the underlayer by means of MBE method to fabricate a zinc blend type CrSb compound.

An underlayer made of a III-V semiconductor compound is formed on a given substrate, and a CrSb compound is epitaxially grown on the underlayer by means of MBE method to fabricate a zinc blende type CrSb compound.

A method for fabricating three-dimensional photonic crystal structures includes providing a layer of photosensitive material; introducing a laser beams into the material; reintroducing the laser beams into the photosensitive material during a second exposure; combining results from at least the first and second exposures to produce a three-dimensionally periodic pattern in the photosensitive material. A related system includes a laser source; a grating array having a plurality of diffraction gratings located thereon; a mask plate located on a photoresist layer and arranged in registration with the grating array; a rotating shutter arranged between the grating array and the laser source, said rotating shutter being suitable for periodically blocking light from the laser source; wherein each of the diffraction gratings is positioned and oriented so as to converge all first-order diffracted spots to a common point lying in a plane of a back side of the mask plate.

Subjects for the invention are to provide a zeolite reduced in performance deterioration in repetitions of use or during long-term use and a process for producing the same and to provide an adsorbent comprising the zeolite and a heat utilization system or the like employing the adsorbent. The invention relates to a zeolite which has a framework density of from 10 T/nm3 to 16 T/nm3 and a carbon content of from 1% by weight to 6% by weight and satisfies the following (1) or (2): (1) the zeolite is an aluminophosphate which has a nitrogen content of from 0.5% by weight to 12% by weight and in which the aluminum may be partly replaced by Me; (2) the zeolite is a silicoaluminophosphate in which the aluminum may be partly replaced by Me and which, when burned to a carbon content lower than 0.3% by weight, retains the framework structure possessed by the silicoaluminophosphate before the burning: (provided that Me in (1) and (2) above is at least one element selected from the elements in Groups 2A, 7A, 8, 1B, and 2B of the periodic table).

A zeolite which has a framework density of 10 to 16 T/nm<3> and a carbon content of 1 to 6 wt %, and satisfies the following (1) and (2): (1) it is an aluminophosphate wherein it has a nitrogen content of 0.5 to 12 wt % and wherein a part of aluminum is optionally substituted with Me, and (2) it is an silicoaluminophosphate wherein a part of aluminum is optionally substituted with Me and wherein when said silicoaluminophosphate is fired into a product having a carbon content of less than 0.3 wt %, the skeleton structure before the firing is retained, where in the above (1) and (2) the Me is at least one element selected from the elements belonging to 2A, 7A, 8, 1B and 2B Groups of the Periodic Table; a method for producing the zeolite; an adsorbent comprising the zeolite; and a heat utilization system or the like using the adsorbent. The above zeolite is reduced in the deterioration of performance capabilities owing to repeated use or the use for a long period of time.

Subjects for the invention are to provide a zeolite reduced in performance deterioration in repetitions of use or during long-term use and a process for producing the same and to provide an adsorbent comprising the zeolite and a heat utilization system or the like employing the adsorbent. The invention relates to a zeolite which has a framework density of from 10 T/nm 3 to 16 T/nm 3 and a carbon content of from 1% by weight to 6% by weight and satisfies the following (1) or (2): (1) the zeolite is an aluminophosphate which has a nitrogen content of from 0.5% by weight to 12% by weight and in which the aluminum may be partly replaced by Me; (2) the zeolite is a silicoaluminophosphate in which the aluminum may be partly replaced by Me and which, when burned to a carbon content lower than 0.3% by weight, retains the framework structure possessed by the silicoaluminophosphate before the burning: (provided that Me in (1) and (2) above is at least one element selected from the elements in Groups 2A, 7A, 8, 1B, and 2B of the periodic table).

The present invention relates to the use of Yersinia outer protein M (YopM), a YopM fragment, or a YopM variant, which is capable of autopenetrating the cell membrane and of integrating into the cell cytosol without the requirement of additional factors for delivering a cargo molecule across the membrane to the cytosol of a cell. The present invention also relates to a pharmaceutical composition comprising YopM, a YopM fragment, or a YopM variant being capable of autopenetrating the cell membrane and of integrating into the cell cytosol without the requirement of additional factors for the regulation of inflammatory reactions of the immune system and the treatment of diseases caused by autoimmunity of the host. The present invention further relates to a YopM fragment or variant, which is capable of autopenetrating the cell membrane and of integrating into the cell cytosol without the requirements of additional factors as well as such proteins or YopM linked to a cargo molecule.